November 5, 2010
UNC Startup Receives Federal Grant to Kick-Start Cancer Research Commercialization
G-Zero Therapeutics funded under Qualifying Therapeutic Discovery Project
November 5, 2010
G-Zero Therapeutics funded under Qualifying Therapeutic Discovery Project
November 5, 2010
In a study published this month in the Journal of Clinical Oncology, the results of a clinical trial of the drug bevacizumab to treat colon cancer in combination with the standard therapy found that the drug did not significantly increase disease-free survival in patients with stage II and stage III colon cancer.
November 5, 2010
Cell signaling protein may hold key to blocking long-studied genetic mutation
November 4, 2010
Matthew Redinbo, PhD, senior author of a study that relates to the drug CPT-11, or Irinotecan, was motivated to tackle the problem of curbing CPT-11’s side effects after seeing the treatment’s debilitating impact on a colleague, Lisa Benkowski, who contracted colon cancer and subsequently died in 2003. For a long time, he did not share …
November 4, 2010
CHAPEL HILL, NC – A debilitating side effect of a widely used but harshly potent treatment for colon cancer could be eliminated if a promising new laboratory discovery bears fruit. The pre-clinical finding, published in the Nov. 5, 2010, issue of the journal Science, relates to the drug CPT-11, or Irinotecan, a chemotherapeutic agent used …
November 1, 2010
CHAPEL HILL, NC – November is Lung Cancer Awareness Month, and UNC’s Mark Socinski, MD, Director of the Multidisciplinary Thoracic Oncology Program, will be part of a national panel sponsored by the Lung Cancer Research Fund in New York City on November 1. The panel focuses on “Key Pieces in the Lung Cancer Puzzle.” Socinski …
October 26, 2010
CHAPEL HILL, NC – Cancer is the leading cause of death in North Carolina, but it doesn’t affect all citizens equally. North Carolina rates of prostate and colon cancer in African-Americans are 47% and 15% higher respectively than in Caucasians, and breast cancer deaths among African-American women are 20 percent higher than for Caucasians. Scientists …
October 25, 2010
CHAPEL HILL, NC – In an editorial in the October 20, 2010 issue of the Journal of Clinical Oncology, UNC’s Richard Goldberg, MD, and Harvard’s Monica Bertagnolli, MD, examine the medical field’s track record of clinical trials for patients who have undergone colon cancer surgery. The topic has been controversial, as selective COX-2 inhibitors such …
October 22, 2010
$11.9 Million in awards to address cancer disparities
October 21, 2010
N.C. native John Isner and doubles partner Sam Querrey to host